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Chlamydia trachomatis is the most commonly diagnosed bacterial sexually transmitted infection and can lead to tubal factor
infertility, a disease characterised by ﬁbrosis of the fallopian tubes. Genetic polymorphisms in molecular pathways involving G
protein-coupled receptor signalling, the Akt/PI3K cascade, the mitotic cell cycle, and immune response have been identiﬁed
in association with the development of trachomatous scarring, an ocular form of chlamydia-related ﬁbrotic pathology. In this
case-control study, we performed genome-wide association and pathways-based analysis in a sample of 71 Dutch women who
attended an STI clinic who were seropositive for Chlamydia trachomatis antibodies and 169 high-risk Dutch women who
sought similar health services but who were seronegative. We identiﬁed two regions of within-gene SNP association with
Chlamydia trachomatis serological response and found that GPCR signalling and cell cycle pathways were also associated with
the trait. These pathway-level associations appear to be common to immunological sequelae of chlamydial infections in both
ocular and urogenital tropisms. These pathways may be central mediators of human refractoriness to chlamydial diseases.
1. Introduction
Chlamydia trachomatis (Ct) is diagnosed as the cause of
around 106 million sexually transmitted infections (STIs)
per annum [1] and has a signiﬁcant impact on global health.
The primary pathology associated with Ct infection is an
aberrant host immune response [2] which can lead to the
progressive formation of scar tissues at and near the site of
infection [3–5]. In the context of STIs, this process can lead
to infection-related tubal factor infertility (TFI) and ectopic
pregnancy [6]. Ct is also the leading infectious cause of blind-
ness [7], and this form of disease (known as trachoma) is
characterised by scar formation on the inner conjunctival
surface of the upper eyelid, leading to lid deformation, cor-
neal damage, and visual impairment. Trachoma has histori-
cally been used as a platform for the study of chlamydial
diseases and their pathology. This is largely due to the relative
ease with which the conjunctiva can be studied compared to
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the fallopian tubes but also because of the high prevalence of
trachomatous scarring in sub-Saharan Africa [8, 9] com-
pared to Ct pathology [10] in Europe and elsewhere.
Whilst serological evidence of historical Ct STIs can be
detected in around a quarter of Northern European women
without current Ct infections [10, 11], it can be very diﬃcult
to ascertain individuals for study who have laparoscopically
conﬁrmed cases of TFI with tubal scarring and concomitant
seropositivity for historical Ct infections (Ct/TFI). In Europe,
the Ct/TFI prevalence in women is likely to be very low, and
in the Netherlands, this was estimated at around 0.08% [10].
This makes the recruitment of participants to research stud-
ies focussed on urogenital chlamydial disease diﬃcult. The
collection of statistically powered case-control samples is
extremely challenging, but it is possible to leverage robust
genetic association data from small samples by deploying sta-
tistical tests that not only collapse the highly dimensional
genetic data to raise power [12] but also iterate over alternate
scenarios to eliminate the burden of multiple testing [13]. We
have used a pathways-based association test that not only
corrects for the length of genes and pathways but also utilises
a process of permutation in which the genotypic associations
of the observed traits were compared to a large number of
simulated trait data sets. This process ensures that any path-
ways that were ultimately linked to the trait are not signiﬁ-
cant simply because of structure within the data, or because
of limitations of the method, or because of the speciﬁc list
of pathways that was chosen.
In our recent discovery phase genome-wide association
study (GWAS) [14], we found that a number of genes and
molecular pathways were associated with TS. That study
applied both a classical single-nucleotide polymorphism
(SNP) association and systems-based analysis [15–17] that
focussed on the cumulative eﬀects of multiple SNPs in the
context of well-deﬁned and curated molecular pathways of
protein-protein interactions [18]. The trachoma GWAS
identiﬁed genome-wide signiﬁcant pathways that were asso-
ciated with the protection and predisposition to TS. These
results indicated a role for genes controlling the immune
response, the mitotic cell cycle, and numerous cell surface
receptors and downstream signalling factors of the G
protein-coupled receptor family. The inference was that the
key factors which protect the host from scarring were pri-
marily innate barriers to initial infection and establishment
of the intracellular niche, rather than direct protection from
the scarring process itself. This interpretation raised a ques-
tion about whether genetic protection might be so extensive
in some people that they are innately refractory to becoming
infected. In these people, we hypothesise that infection might
never progress to the point that stimulates a lasting adaptive
serological or cellular immune response.
The aim of this work was to assess the extent to which
sexually transmitted Ct infections might share a common
pathway of genetic predisposition with trachoma. By focus-
sing on a trait of seropositivity for anti-Ct antibodies in
high-risk, presumably exposed Dutch women attending STI
clinics, we investigated if pathway-wide polymorphisms in
the host are associated to primary events of infection. This
work takes the form of a GWAS in a small case-control
sample in which we tested the association of 1345 multigene
pathways, 590,811 directly genotyped SNPs, and 8,852,410
imputed SNPs with serological status in 240 women attend-
ing a sexual health clinic in the Netherlands.
2. Methods
2.1. Ethics Statement. This study used archival material and
linked data from clinical tests that had been irreversibly
anonymised. The Medical Research Involving Human Sub-
jects Act (WMO, Dutch Law) states that oﬃcial approval of
the study by the Medical Ethical Committee is not required
for research using the anonymous human material collected
for this study (MEC Letter reference: number 10.17.0046).
All subjects gave written informed consent for their speci-
mens and data to be used in this way. All antecedent clinical
studies were conducted in accordance with the tenets of the
Declaration of Helsinki.
2.2. Study Population, Sampling, and Ascertainment. 244
Dutch Caucasian women were selected from a larger study
consisting of Dutch Caucasian women visiting an outpatient
sexual health clinic in Amsterdam, Netherlands, between July
2001 and December 2004. The women used a self-completion
questionnaire to describe their symptoms at presentation,
which varied from increased vaginal discharge, having bloody
discharge during and/or after coitus, recent abdominal pain
(not gastrointestinal or menses related), and/or dysuria.
2.3. Genotyping and Quality Control. All specimens (n = 244)
were genotyped at 713,599 SNPs using the Inﬁnium
OmniExpress-24 v1.2 Kit (Illumina). Basecalling was per-
formed using Illuminus [19]. SNPs were retained in the
analysis if (a) the call rate was ≥0.99, (b) the minor allele
frequency was ≥0.01, and (c) Hardy-Weinberg equilibrium
p value >5× 10−8. 590,811 directly genotyped SNPs were
retained after QC.
PLINK and R were used to test for between-individual
proportional IBS variance and to perform kinship estimation
by identity by state/allele sharing estimation. Individuals
were removed if they were identiﬁed as being outliers
because they had (a) >10% missing genotype data, (b) iden-
tity by descent (IBD) sharing with another individual of two
alleles at all loci, (c) identity by state with the ﬁfth nearest
neighbour with Z < −4 compared to the mean IBS of all pos-
sible pairs, or (d) unresolved gender mismatch between sex
chromosome genotypes and clinical record. After these QC
steps, 240 specimens were retained as one failed the pairwise
IBD test and three failed the ﬁfth nearest neighbour-based
outlier analysis.
2.4. Statistical Power. The R package “gap” [20] was used to
estimate the power of the study to detect genome-wide signif-
icant (<1× 10−8) associations of individual SNPs. At this level
of signiﬁcance, a study of 71 cases and 169 controls has 80%
power to detect allele frequency odds ratios (OR) of 22.89, for
minor allele frequency (MAF) in the control group of 0.1.
The small sample size of this study meant that we could not
diﬀerentiate between null results and false negatives. The
false positive rate of SNP-based genome-wide association
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tests was meanwhile controlled using the Bonferroni process.
The false discovery rate of pathway analysis was controlled
using a robust permutation process, which allows multiple
testing at no increased cost to power [12, 13].
2.5. Imputation. Imputation was carried out as described
previously [21, 22] and included prephasing with SHAPEIT
[23, 24] (informed by HapMap Phase II, build 37) and post-
imputation ﬁltering for high-quality imputed SNPs with
IMPUTE2 info score > 0 8 and/or MAF > 0 01 [14, 25].
Imputation was performed with IMPUTE2 [21, 22] using
the worldwide 1000 Genomes phase I data set of 1092 refer-
ence specimens [26]. 20,514,944 SNPs were imputed, and
after ﬁltering, 9,443,221 SNPs were retained for association
testing analysis.
2.6. Tests of Association.Wemodelled the clinical status (sero-
positive/seronegative) according to age using logistic regres-
sion. Residuals of the regression were taken forward as the
serological status trait in the association test. Tests of associa-
tion of SNPs with age-corrected phenotypes were performed
using EMMAX [27]. All tests of association were performed
using a pairwise matrix of IBS kinship estimates which was
generated from the SNP data. SNPnexus (http://snp-nexus.
org) was used to annotate the SNPs with P < 1 ∗ 10−6.
2.7. Pathway Analyses.The R package SNPath (https://github.
com/lschen-stat/SNPath) was used to run the Assignment
List GO AnnotaTOR (ALIGATOR) algorithm [12] on 1345
Reactome pathways [18]. In order to make the results directly
comparable to those of the previous study [14], we chose to
use the same pathway list that was used in that analysis
(http://www.reactome.org/, accessed April 2013). The p
values from EMMAX tests of association were sampled
to remove SNPs that were > 20 kb away from any gene
in a list of ~17,000 genes that were consistently cross-
referenced between Entrez and Ensembl and for which a
HUGO gene name had been assigned https://github.com/
lschen-stat/SNPath. ALIGATOR requires the user to spec-
ify a nominally signiﬁcant threshold value, and particularly
when the sample size is low, this choice can signiﬁcantly
aﬀect the membership of the list of signiﬁcant pathways.
More stringent values for this threshold (i.e., 0.0001) will
focus on SNPs most likely to be true positives (at the level
of SNP) whilst more relaxed (i.e., 0.01) thresholds will
capture more information from genes of small individual
eﬀect and may give a better indication of pathway involve-
ment in diseases [12]. We chose to investigate the way in
which threshold aﬀected membership of the results table
by running ALIGATOR at three thresholds of PEMMAX
(0.0001, 0.001, and 0.01) and combining the results. We
used 5000 permutations of the PEMMAX values at each
threshold. A list of all genes that appeared in any signiﬁ-
cant pathway at any threshold was generated, and this list
was functionally annotated using DAVID Bioinformatics
Resources 6.7 [28] to identify enriched Reactome pathways
and GO terms, whilst accounting for the signiﬁcant gene
content overlap in speciﬁc pathways.
2.8. Serological and Infection StatusDetermination.Peripheral
venous blood was collected for the analysis of IgG anti-
bodies against C. trachomatis (CT) using Chlamydia tra-
chomatis-IgG-ELISA plus medac (Medac Diagnostika
mbH, Hamburg, Germany). This test uses a synthetic pep-
tide of a variable domain from an immune-dominant
region of the major outer membrane protein (MOMP)
and has been shown to perform with high speciﬁcity
(~0.95–0.97) when evaluated against both Pgp3 and MIF
[29]. A Ct IgG titre of ≥1 : 50 was considered positive.
Samples with values within ±10% of the 1 : 50 cut-oﬀ
value were repeated and considered positive when the
result was positive or still within the ±10% range of
the cut-oﬀ [30, 31]. The distribution of IgG titres in
the positive population was as follows: titre (T) = 1 : 50
[n = 9], T = 1 : 100 [n = 19], T = 1 : 200 [n = 24], T = 1 : 400
[n = 9], T = 1 : 800 [n = 7], and T = 1 : 1600 [n = 3]. In the
negative population, all specimens had a titre of T = 1 : 1
[n = 169]. Tests for infection were performed on endocer-
vical swabs using the COBAS AMPLICOR CT/NG Test
(Roche, Basel, Switzerland).
3. Results
There were 71 seropositive and 169 seronegative individuals
(n = 240) in the analysis. All 71 seropositive cases were
additionally infection-positive, whilst all 169 seronegative
cases were infection-negative. Cases were signiﬁcantly
younger than controls in this sample (p = 0 007). The
median age of cases was 23 (min 16, 1st quartile 19.5, mean
22.6, 3rd quartile 24.5, and max 30). The median age of
controls was 24 (min 15, 1st quartile 21, mean 23.8, 3rd
quartile 27, and max 32). The genome-wide inﬂation statistic
was =1.04 before correcting for age and =1.02 after correction
(Supplementary Figure 1).
In the genome-wide association study (GWAS), 46 single-
nucleotide polymorphisms (SNPs) with PEMMAX < 1E − 6
were identiﬁed (see Supplementary Table 1). These were
located in ﬁve regions (A–E, see Table 1). Although none of
the individual SNPs reached genome-wide signiﬁcance
(1E− 8), regions B (Figure 1(b)) andC (Figure 1(c)) contained
33 and 12 SNPs, respectively.
The 33 SNPs in region B lay within the nonprotein-
coding NPSR Antisense RNA1 (NPSR1-AS1) and immedi-
ately upstream of the G protein-coupled receptor coding
neuropeptide S receptor 1 (NPSR1) (Figure 1(b)). The 12
SNPs in region C lie in the protein kinase, CGMP-dependent,
type I (PRKG1) (Figure 1(c)), a mediator of the nitric oxide/
cGMP signalling pathway, which has roles in immune
function and in GPCR signalling.
Sixty-six diﬀerently named Reactome pathways were
identiﬁed as signiﬁcantly enriched (pperm < 0 05) in chla-
mydial seropositivity. These pathways (Supplementary
Table 2) are the combination of results from three ALI-
GATOR [12] pathway analyses with SNP cut-oﬀ thresh-
olds of 0.01, 0.001, and 0.0001. The number of SNPs
reaching each of the cut-oﬀ values were 93,106 (p <
0 01), 9998 (p < 0 001), and 1168 (p < 0 0001). The num-
bers of SNPs mapping to genes at each threshold were
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64,397 (p < 0 01), 6.274 (p < 0 001), and 451 (p < 0 0001).
The number of signiﬁcant pathways at each cut-oﬀ were 17
(p < 0 01), 20 (p < 0 001), and 33 (p < 0 0001). In total, these
pathways contained 2556 unique genes. Clustering the
Reactome pathways by genic intersection demonstrated a
large gene overlap (Figure 2).
The Reactome “Signalling by GPCR” and “Cell Cycle,
Mitotic” pathways contained 563 and 299 genes out of
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Figure 1: Results of GWAS analysis for Chlamydia trachomatis seropositivity using EMMAX. (a) Manhattan plot showing index SNPs
with pEMMAX < 1 × 10 – 6. There were two regions of within-gene SNP association with Chlamydia trachomatis serological response.
(b) The Chr 7: 34560375–34666861 region, within the nonprotein-coding NPSR1 antisense RNA 1 (NPSR1-AS1) and immediately
upstream of the G protein-coupled receptor coding neuropeptide S receptor 1 (NPSR1). (c) The Chr 10: 53873323–56733116 region,
within the gene encoding protein kinase, CGMP-dependent, type I (PRKG1), a mediator of the nitric oxide/cGMP signalling pathway,
which has roles in immune function and GPCR signalling.
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2556 total genes (23.3% and 12.4%, resp.). Using the Gene
Ontology (GO) database, over 10% of genes were assigned
to the GO biological processes (GO-BP): “Cell surface
receptor linked signal transduction,” “G-protein coupled
receptor signalling pathway,” and “Sensory perception of
smell.” This ﬁnal process shows a large genic overlap with
the “Signalling by GPCR” Reactome pathway (Figure 2).
The “Plasma membrane” (GO cellular component (GO-
CC)) and “Olfactory receptor activity” GO molecular
function (Go-MF) are also enriched. The full list of signif-
icant pathways, with gene count and Benjamini-Hochberg
tests, can be found in Supplementary File 1.
4. Discussion
In this study, we have identiﬁed two candidate
regions of genetic association with anti-Ct serological status
(pEMMAX < 5 × 10−6) in Dutch women attending sexual
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Figure 2: Gene content clustering of signiﬁcant pathways in ALIGATOR analysis under three thresholds for nominal signiﬁcance.
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health clinics for which there was at least one supporting SNP
in LD with R2 > 0 6. One of these genomic regions of associ-
ation was within the protein kinase, CGMP-dependent, type
I gene (PRKG1) whilst another was within NPSR1 antisense
RNA 1 (NPSR1-AS1), which presumably has a role in
posttranscriptional control of the nearby gene neuropeptide
S receptor 1 (NPSR1).
The PRKG1 protein is a cytosolic cyclic GMP-dependent
protein kinase that has a role in signalling via the cRaf-
MEK1/2-Erk-cMyc/cJUN axis. This may be important in
chlamydial disease as the trachoma GWAS [14] identiﬁed
an association between pathways of signalling through ﬁbro-
blast growth factor receptors (FGFRs). We suggested that this
system could be a crucial component in predisposition to tra-
chomatous scarring. One pathway of signalling from FGFRs
to the nucleus involves signal transduction through FRS2,
Grb2/SOS, and Ras, which then intersects with the cRaf-
MEK1/2-Erk-cMyc/cJUN axis.
NPSR1 is a G protein-coupled receptor that has been
linked to asthma susceptibility [32] and inﬂammatory bowel
disease [33]. NPSR1 interacts with phospholipase C and like
both PRKG1 and PREX2 (the best candidate associated gene
from the trachoma GWAS [14]) is part of the G protein-
mediated cascade of intracellular signalling that centres
around the PI3K/Akt pathway of cell cycle regulation. Kecha-
gia and colleagues showed that trachoma ﬁbroblasts could
promote Akt phosphorylation in macrophages in an IL-6-
dependent manner [34]. They went on to suggest that
increased IL-6 secretion in trachoma may sustain macro-
phage activation and survival, with the knock-on eﬀect that
this could enhance the contractile activity of the ﬁbroblasts
and lead to more severe scarring. Whether the role for the
PI3K/Akt pathway in trachoma is to protect against primary
infection, or against progression to scarring, or both things, is
a matter that requires further study.
This study has some signiﬁcant limitations. The sample
used in this study was very small, and the SNP-based analyses
presented in this paper are therefore critically underpowered.
Whilst we are conﬁdent that the positive signals from the
PRKG1 and NPSR1-AS1 region are interesting enough to
warrant further study, we recognize that the false-negative
rate is very high. To leverage additional power from the small
sample, we focussed on pathway-wide analysis that was sim-
ilar to the one used previously [14]. We determined that the
ALIGATOR method was somewhat unstable with regards to
the speciﬁc pathways that were highlighted at diﬀerent
thresholds of nominal signiﬁcance (Supplementary Table 2).
This is no doubt because more permissive nominal cut-oﬀ
values (i.e., p < 0 01) lead to a more sensitive analysis that
identiﬁesmore pathways but lacks themore granular speciﬁc-
ity ofmore conservative thresholds (i.e., p < 0 0001). Collating
the results of three diﬀerent runs of the ALIGATOR analysis
allowed us to average across the various sources of error (false
negatives versus false positives) whilst identifying pathways.
When we assessed the data with functional analysis using
DAVID [28], the results pointed towards the importance of
cell cycle andGprotein-coupled receptor-mediated signalling
(Supplementary File 1). By testing for a limited number of
pathways whilst utilizing permutation based estimators of
signiﬁcance, we have been able to robustly detect signals of
pathway-wide association with chlamydial seropositivity
that are almost identical to the ﬁndings of the previous
study in trachoma.
We identiﬁed potential roles for pathways relating to
PI3K/Akt signalling, FGFRs, and control of the cell cycle.
G-PCRs and their signalling pathways were previously
highlighted in trachoma cases [14, 35] and also in Chlamydia
muridarum infection in the BXD recombinant inbred mouse
[36]. Neural growth factor receptor (NGFR) pathways were
also strongly associated with serostatus in the Dutch popula-
tion. Derrick and colleagues [37] previously showed that
numerous gene and pathway targets of trachoma-associated
microRNA moieties were neuronal related.
We also detected a signiﬁcant role for olfactory receptor
signalling cascades in this study (Supplementary File 1). This
could be accounted for by the substantial overlaps between
the genes involved in olfactory signalling and the G
protein/PI3K signalling system. The olfactory system has
however been independently linked to C. pneumoniae infec-
tions and subsequent ﬁbrillogenic Alzheimer’s like plaque
formation in the olfactory centres of mouse brains [38].
Given that such plaques involve collagen restructuring and
might be considered akin to the scars that succeed human
Ct infections, it seems reasonable to infer that the various
Chlamydiaceae can utilise a variety of diﬀerent, but related,
cell surface receptors to gain access to the host cell at diﬀerent
body sites. These diverse receptors may well share a common
downstream signalling process via G proteins and particu-
larly via the PI3K pathway. Collectively, these data appear
to conﬁrm that G protein-coupled receptor signalling path-
ways and the cell cycle are associated with chlamydial infec-
tions in a way that transcends tissue tropisms and which
might be utilised by many or all chlamydial species in their
animal hosts. In the absence of an appropriate replication
panel for the more granular analyses of the SNP-based asso-
ciation tests, we infer more meaning from the functional
overlap of the pathways identiﬁed in this study and the pre-
vious GWAS in trachoma. We interpret our data in the
broadest sense, which is that the key pathways identiﬁed
between the studies have substantial functional and gene
content overlap. A cross-study comparison of the ‘p values’
for any speciﬁc pathway is not however an appropriate way
to interpret this overlap, largely because the high false neg-
ative risk leads to a certain instability in the association
test results. With this small study, we are unfortunately
not able to quantify the convergence of the results between
the studies.
Another limitation of the study that we highlight is that
trait of sero-positivity was measured using a single antigen
(MOMP) test. It was not possible to prove unequivocally that
all the women who were included in the study as controls had
been exposed to C. trachomatis infections, nor that coinfec-
tion with other microorganisms was not a complicating fac-
tor in the clinical presentation of our cases, but this study
was carried out in the context of a population of women seek-
ing test and treatment, who were thought to be at very high
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risk for exposure to C. trachomatis STI. Our control group
had a uniform antibody titre of 1 : 1, whilst the majority of
positives had high titres (mode 1 : 200).
We have selected statistical analysis methods for the
pathway analysis that allow for a high multiplicity of testing,
whilst not imposing the same burden of signal loss that are
associated with more rudimentary corrections such as
Bonferroni’s method. They also collapse highly dimensional
data, leading to a better powered ‘burden’ test. In the light
of the robust permutation-based analysis, we used the
remarkable similarities between our ﬁndings and those of
the previous trachoma GWAS; it is extremely unlikely that
these associations have been identiﬁed in both the trachoma
and STI tropisms either by chance or because of systematic
errors in our analysis approach.
By focussing on a trait that is generally accepted to indi-
cate lifetime responses to infectious challenge, we believe that
we have identiﬁed pathway-wide genotypes that appear to
associate with protection from infection in some women.
This protection could take the form of a partial or complete
refractoriness to primary cellular infection, or a rapid,
intense, and highly eﬀective innate immune response.
5. Conclusions
Between the tissue tropisms of the eye and the genital tract, the
pathway-wide genetic risk and protection patterns overlap to
a substantial degree. This supports amodel under which com-
mon pathways of intracellular signalling might be utilised by
all Chlamydiaceae, even though the speciﬁc receptors that
mediate introgression into the cell might be highly variable.
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